Let me know when the data is updated again

DARFARMA SA DE CV

Summary of sales of medicines and medical supplies

927 purchase as supplier for a total of 185.9 millones (185,861,521.427 ) between 2014 and 2019.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

66.7 millones pesos mexicanos (66,670,143.39 MXN)

Overcost in %

85.4 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
DORZOLAMIDA Y TIMOLOL 21 14.6 millones MXN 2.4 millones MXN 23.2 % 2014 - 2018
CEFOTAXIMA 20 15.5 millones MXN 2.9 millones MXN 50 % 2015 - 2016
ACETAZOLAMIDA 17 3.1 millones MXN 839,246.9 MXN 39.1 % 2017 - 2018
CEFTRIAXONA 14 3.2 millones MXN 1.4 millones MXN 83.2 % 2015 - 2017
CROMOGLICATO DE SODIO 14 1.3 millones MXN 277,152.1 MXN 23.1 % 2017 - 2018
TACROLIMUS 13 12.6 millones MXN 7.4 millones MXN 140 % 2014 - 2019
NIFEDIPINO 12 1.5 millones MXN 321,241.1 MXN 35.8 % 2015 - 2018
INDOMETACINA 12 190,689.6 MXN 56,886.4 MXN 78.3 % 2014 - 2018
CELECOXIB 12 13.6 millones MXN 11.6 millones MXN 665.2 % 2018 - 2018
PIROXICAM 11 848,597.8 MXN 60,081.8 MXN 4.75 % 2016 - 2016

Location

Country

México

GENERAL INFORMATION

Alternative names

  • DARFARMA, S.A. DE C.V.
  • DARFARMA S.A. DE C.V.

Entity type

profit

Identifiers

RUPC: 406993

RFC: DAR1408188Y7

Date updated in QQW

24 de enero de 2019

Organization responsible for the import

PODER